AJR 2001; 176:1408
© American Roentgen Ray Society
Radiologic-Pathologic Conferences of the Massachusetts General
Hospital |
Posterior Mediastinal Pheochromocytoma
Steven Chao1,
Mark E. Mullins and
Priscilla J. Slanetz
1
All authors: Department of Radiology, Division of Breast Imaging, ACC 219,
Massachusetts General Hospital, 32 Fruit St., Boston, MA 02115.
Received October 2, 2000;
accepted after revision December 4, 2000.
From the weekly radiologic-pathologic correlation conferences conducted by
Theresa C. McLoud.
Address correspondence to P. J. Slanetz.
Introduction
A 19-year-old man with labile hypertension refractory to pharmacologic
treatment, severe headaches, palpitations, diaphoresis, and dizziness
underwent chest radiography that showed a rounded opacity along the right
heart border (Fig. 1A). MR
imaging revealed a 6 x 6 x 3 cm paravertebral rightsided posterior
mediastinal mass centered at T8-T9 with a salt-and-pepper appearance
(Fig. 1B) and mild scalloping
of the vertebral bodies. Measurement of elevated levels of norepinephrine,
metanephrines, and vanillylmandelic acid in 24-hr urine collections and
single-photon emission computed tomography visualization of intense uptake of
pentetreotide tracer by the mass confirmed the diagnosis of extraadrenal
pheochromocytoma. The patient underwent thoracotomy and resection of the
posterior mediastinal mass (Fig.
1C). Microscopic histopathology revealed a well-circumscribed
encapsulated nodular lesion containing highly vascularized nests of cells. The
final pathologic diagnosis was pheochromocytoma
(Fig. 1D).

View larger version (115K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B. 19-year-old man with labile hypertension, headaches,
palpitations, and diaphoresis. Coronal T1-weighted MR image shows
characteristic salt-and-pepper appearance of paraspinal mass, confirming
diagnosis of pheochromocytoma.
|
|

View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1C. 19-year-old man with labile hypertension, headaches,
palpitations, and diaphoresis. Gross pathology specimen shows well-demarcated
nodular right posterior mediastinal mass (seen on A and B).
(Reprinted with permission from
[5])
|
|

View larger version (167K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1D. 19-year-old man with labile hypertension, headaches,
palpitations, and diaphoresis. Photomicrograph of specimen shows round nests
of large regular polyhedral cells separated by congested capillaries. Note
acellular tumor capsule. Both capillaries and capsule are typical of
pheochromocytoma. (H and E, x100)
|
|
Pheochromocytomas are vascularized chromaffin cell neoplasms that secrete
catecholamines and, in some cases, other active peptides; they are responsible
for approximately 0.1-0.5% of patients with hypertension
[1]. The classic symptoms
accompanying hypertension with pheochromocytoma are headache, palpitation, and
excessive sweating. Pheochromocytomas are a curable cause of hypertension but
can be fatal if not recognized. In the adult population, 10% are extraadrenal,
usually derived from the chromaffin cells of the sympathetic ganglia. Most
(98%) pheochromocytomas are in the abdomen and are associated with the celiac,
superior mesenteric, and inferior mesenteric ganglia. Approximately 1% occur
in the thorax. Histopathologically, pheochromocytomas have cells arranged in
small clusters separated by prominent fibrovascular stroma.
Elevation of catecholamine levels and their metabolites in 24-hr urine
collections is diagnostic of pheochromocytoma if the patient is hypertensive
or symptomatic at the time of collection. Although unenhanced radiography and
CT can localize the tumor, MR imaging is the technique of choice. A recent
study found MR imaging to be 88% sensitive, 98% sensitive, and 100% sensitive
for the detection of extraadrenal, unilateral adrenal, and bilateral adrenal
lesions, respectively [2]. The
salt-and-pepper appearance of these tumors on MR imaging is characteristic,
with the pepper representing flow voids of vessels and the salt representing
the T1 bright tumor parenchyma. 131I-metaiodobenzylguanidine
(MIBG), which is concentrated in pheochromocytomas by the amine uptake
process, is 85% sensitive and 95% specific for detecting these tumors
[3]. Other imaging methods such
as 111In-octreotide scintigraphy and positron emission tomography
with 18F-fluorodeoxyglucose, complement and supplement MIBG
imaging. IV contrast material should be administered with caution because
hypertensive crisis can be precipitated. Percutaneous fine-needle biopsy is
contraindicated for similar reasons.
Treatment of isolated benign tumors is surgical; perioperative surgical
mortality is 2-3%. Hypertension and its symptoms generally resolve after
surgery, although some patients require long-term pharmacologic treatment.
Five-year survival after surgery is greater than 95%, and recurrence is less
than 10%. Malignancy is determined by metastasis and occurs more frequently in
extraadrenal than in adrenal pheochromocytomas
[4].
References
-
Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin
North Am 1996;34:1101
-1112[Medline]
-
Jalil ND, Pattou FN, Combemale F, et al. Effectiveness and limits
of preoperative imaging studies for the localisation of pheochromocytomas and
paragangliomas. Eur J Surg
1998;164:23
-28[Medline]
-
Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH.
Iodine-131 metaiodobenzylguanidine for the locating of suspected
pheochromocytoma: experience in 400 cases. J Nucl Med
1985;26:576
-585[Abstract/Free Full Text]
-
Whalen RK, Althausen AF, Daniels GH. Extra-adrenal
pheochromocytoma. J Urol
1992;147:1
-10[Medline]
-
Conlin RP, Faquin WC. A 19-year-old man with bouts of hypertension
and severe headaches. N Engl J Med
2001;344:1314
-1320[Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Paul, S. H. Jain, R. P. Gallegos, S. F. Aranki, and R. Bueno
Functional Paraganglioma of the Middle Mediastinum
Ann. Thorac. Surg.,
June 1, 2007;
83(6):
e14 - e16.
[Abstract]
[Full Text]
[PDF]
|
 |
|